Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR2T35 Inhibitors

Chemical inhibitors of olfactory receptor 2T35 employ various methods to inhibit its function. Tetrodotoxin (TTX), by selectively inhibiting voltage-gated sodium channels, prevents the depolarization required for the initiation and propagation of action potentials in neurons, thus impairing the ability of olfactory receptor 2T35 to trigger olfactory signal transduction. Similarly, quinine blocks potassium channels, affecting the repolarization phase of action potentials and altering the electrical activity necessary for olfactory receptor 2T35's function. This leads to the inhibition of the receptor's activity by affecting the neuron's ability to transmit signals. Ruthenium Red and Lanthanum(III) chloride inhibit calcium channels, decreasing intracellular calcium levels crucial for the olfactory signal transduction pathway, thereby inhibiting the receptor's function by impairing signal amplification and calcium-mediated signaling processes. Furthermore, compounds such as Capsazepine and SK&F 96365 target the TRPV1 and TRPC channels, respectively, which are involved in the detection of chemical stimuli and calcium signaling pathways important for olfactory receptor function. By inhibiting these channels, they dampen the signaling pathways that olfactory receptor 2T35 relies on. Amiloride and BAPTA/AM, by selectively inhibiting epithelial sodium channels and chelating intracellular calcium, respectively, reduce the ion influx necessary for depolarization and the initiation of action potentials or calcium-mediated signal transduction. This results in the inhibition of olfactory receptor 2T35 by preventing proper signal transmission and calcium signaling. Additionally, DIDS, by disrupting ionic balance through the inhibition of anion exchangers and chloride channels, and Conotoxin and Methyllycaconitine, by targeting specific calcium and nicotinic acetylcholine receptors, further contribute to the inhibition of olfactory receptor 2T35 by affecting various aspects of cellular signaling crucial for its activation and function. These chemical inhibitors collectively demonstrate the multifaceted approach to inhibiting olfactory receptor 2T35, focusing on disrupting the intricate cellular and molecular processes essential for its activity.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Ruthenium red

11103-72-3sc-202328
sc-202328A
500 mg
1 g
$184.00
$245.00
13
(1)

Ruthenium Red is known to block calcium channels. By inhibiting calcium channels, it decreases intracellular calcium levels, which are crucial for the function of olfactory receptors, including olfactory receptor 2T35, as calcium is involved in the olfactory signal transduction pathway. This results in the inhibition of olfactory receptor 2T35 activity by impairing signal amplification.

Capsazepine

138977-28-3sc-201098
sc-201098A
5 mg
25 mg
$145.00
$450.00
11
(1)

Capsazepine, a TRPV1 antagonist, inhibits the transient receptor potential cation channel subfamily V member 1. This channel is involved in the detection of chemical stimuli that can activate sensory neurons. Inhibiting TRPV1 can dampen the signaling pathways that olfactory receptor 2T35 may rely on for initiating olfactory signal transduction, leading to its functional inhibition.

Quinine

130-95-0sc-212616
sc-212616A
sc-212616B
sc-212616C
sc-212616D
1 g
5 g
10 g
25 g
50 g
$77.00
$102.00
$163.00
$347.00
$561.00
1
(0)

Quinine is a known blocker of various ion channels, including potassium channels. By inhibiting potassium channels, it affects the repolarization phase of the action potential in neurons. This inhibition can alter the signaling pathway of olfactory receptor 2T35 by affecting the electrical activity necessary for its proper function, thus inhibiting its activity.

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$449.00
61
(2)

BAPTA/AM is a cell-permeable calcium chelator that effectively lowers intracellular calcium levels. Since calcium plays a pivotal role in the signal transduction mechanism of olfactory receptors, including olfactory receptor 2T35, chelating intracellular calcium can lead to the inhibition of this receptor's signaling pathways, thereby inhibiting its functional activity.

Methyllycaconitine citrate

112825-05-5sc-253043
sc-253043A
5 mg
25 mg
$117.00
$398.00
2
(1)

Methyllycaconitine is an antagonist of the nicotinic acetylcholine receptor. Although not directly related to olfactory receptors, by inhibiting nicotinic acetylcholine receptors, it can indirectly influence the neuronal excitability and neurotransmitter release affecting the olfactory system. This can lead to reduced activation of olfactory receptor 2T35, resulting in its functional inhibition.

SK&F 96365

130495-35-1sc-201475
sc-201475B
sc-201475A
sc-201475C
5 mg
10 mg
25 mg
50 mg
$101.00
$155.00
$389.00
$643.00
2
(1)

SK&F 96365 inhibits receptor-mediated calcium entry channels, including TRPC channels. Since TRPC channels are involved in the calcium signaling pathway important for olfactory receptor function, inhibiting these channels can decrease the activity of olfactory receptor 2T35 by preventing calcium-mediated signal transduction.

Amiloride • HCl

2016-88-8sc-3578
sc-3578A
25 mg
100 mg
$22.00
$56.00
6
(2)

Amiloride selectively inhibits epithelial sodium channels (ENaC). By inhibiting ENaC, it reduces sodium influx, which is necessary for depolarization and the initiation of action potentials in olfactory sensory neurons. This inhibition can indirectly lead to the functional inhibition of olfactory receptor 2T35 by impairing olfactory signal transmission.

Lanthanum(III) chloride

10099-58-8sc-257661
10 g
$88.00
(0)

Lanthanum(III) chloride is a blocker of calcium channels. By blocking calcium channels, it inhibits calcium influx into cells, which is critical for the signaling processes of many receptors, including olfactory receptors. This inhibition of calcium signaling pathways leads to the functional inhibition of olfactory receptor 2T35 by impairing its ability to participate in olfactory signal transduction.